Thursday - 27/06/2019
Topics
Meeting category
Date(s)
27 Jun 2019 - 29 Jun 2019
Location
Hong Kong,
Hong Kong
2
Organizer
Titanium Level Support
Sponsor logos
APACC 2019
Related Enduring Materials
Enduring Materials
Opening session: Transition to Domestic/Regional Funds -
The UNAIDS perspective
Discussion
Parallel Session 1: Novel Treatment Strategies -
Novel Treatment Strategies for LMICs
Turning Challenges into Opportunities: Preventing and Treating HIV Infection among Adolescents
Parallel Session 2: The Real-life Facets of PrEP -
Practical Perspective of the Use of Point-of-care Testing for Supporting the Delivery of HIV Pre-exposure Prophylaxis ((No permission for publication))
Tsz Ho Kwan
#1
A Mathematical Model of HIV Prevention Strategies in Japanese MSM
Stuart Gilmour
#2
Starting PrEP during Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance?
Donn Colby
#3
Factors Associated with Transitioning from Post-exposure Prophylaxis To Pre-exposure Prophylaxis at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: A five-year observational cohort
Tanat Chinbunchorn
#4
Demographic Characteristics and Risk Behaviors of Transgender Women Using Free Versus Fee-based Pre-exposure Prophylaxis (PrEP) Services in Bangkok, Thailand
Rena Janamnuaysook
#5
Parallel Session 3: What to Consider when Initiating ART? -
A Quality Improvement Learning Network Approach to the Reduction of HIV-related Stigma and Discrimination in Healthcare Settings
Bruce Agins
#6
Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-tablet Antiretroviral Regimens ((No permission for publication) )
Sui-Yuan Chang
#7
Early Mortality After Late Initiation of Antiretroviral Therapy in the TREAT Asia HIV Observational Database (TAHOD) of IeDEA Asia-Pacific
Dhanushi Rupasinghe
#8
Rapid Antiretroviral Initiation among Thai HIV-infected Youth Through the National AIDS Program in the Era of Treatment at Any CD4
Sirinya Teeraananchai
#9
Dual Therapy with Lopinavir/ritonavir plus Lamivudine could be a Long-term viable alternative for antiretroviral-therapy-naive adults in resource-limited Settings: 144-week Results from a Randomized, Open-label, Non-inferiority Study from China
Linghua Li
#10
Capacity-building Session 1: Preparing for Publication in Lancet Journals -
Capacity Building Session
Friday - 28/06/2019
Plenary Session 2: Progress in HIV Cure/Elimination -
Diagnosing and Treating Acute HIV Infection – Implications for HIV Cure
Parallel Session 4: Key Population Empowerment -
Key Pop-led HIV Service Delivery – Focus on Transgenders
Blued Experience with Empowering MSM in the HIV Response (No permission for publication)
Dapeng Zhang, MD, PhD
BlueD, China
Parallel Session 5: New Issues and Strategies in Hep B and Hep C -
Prognostic Factor for Natural Eradication of Acute Hepatitis C Infection in HIV Positive Patients (No permission for publication)
Haruka Uemura
#11
HCV Seroepidemiology among HCV-seronegative, HIV-positive Patients in Northern Taiwan: An Expanding Epidemic
Li-Hsin Su
#12
Interim Analysis of a Randomized Clinical Trial: HBV Revaccination among HIV-positive MSM Born in the Era of Neonatal Immunization
Yi-Chia Huang
#13
Long-term Virological and Serologic Responses of Chronic Hepatitis B Virus infection to Tenofovir Disoproxil Fumarate-containing Regimens in Patients with HIV and Hepatitis B Co-infection
Sung-Hsi Huang
#14
HCV Reinfections after Viral Clearance among HIV-positive Patients with Recent HCV Infection in Taiwan
Miao-Hui Huang
#15
Parallel Session 6: Gone with the Wind or Not? Opportunistic and Co-infections -
The Relationships Between anal Intraepithelial Neoplasia, Oncogenic HPV and microbiota in gay, bisexual, and Other Men Who Have Sex with Men and Have HIV Infection
Shu-Hsing Cheng
#16
Incidence, Persistence and Factors Associated with High-risk Human Papillomavirus infection among Male Adolescents with Perinatally Acquired HIV Infection in Thailand
Annette H. Sohn
#17
Paradoxical Immune Reconstitution Inflammatory Syndrome Associated With Talaromyces Marneffei Infection Among ART-Naïve Population
Thanh Nguyen Tat
#18
A prospective study of the Talaromyces marneffei mannoprotein Mp1p enzyme immunoassay for early detection of Talaromyces marneffei infection in patients with advanced HIV disease in Vietnam
Ly Vo Trieu
#19
The effects of human papillomavirus (HPV) vaccination on the persistence of high-risk HPV infection and abnormal cervical cytology among sexually active female adolescents with and without perinatally acquired HIV
Pradthana Ounchanum
#20
Capacity-building Session 2: Critical reading/bias in clinical research -
Capacity Building Session 2
Parallel Session 8: HIV Testing? the Answer is Yes, Stupid! -
We are Ready! Willingness to Pay and Preferred Delivery Point of Service for HIV Self-Testing Kits Among Men Who Have Sex with Men and Transgender Women in Thailand
Acceptability and experiences of assisted and unassisted oral fluid testing among men who have sex with men and transgender women in Thailand: Implications to roll out and scale-up
Increased HIV Testing and Case Finding Targeting Young Men who Have Sex with Men in Bali Through Private & Government Partnership
Unassisted HIV Self-testing in Vietnam
Photographic Verification of Self-reported HIV Self-testing Results among Chinese Men who Have Sex with Men: an Iinterim Analysis
Parallel Session 9: The Challenges in ART Retention -
Back to ART (B2A) Initiative in Yunnan Province, China
A Dual Analysis of Loss to Follow-up for Perinatally HIV-infected Adolescents Receiving Combination Antiretroviral Therapy in Asia
Differentiated Care Delivery Through Telemedicine for PLHIV in the Philippines
Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Perinatally HIV-infected Adolescents in Asia
Debate: Same-day ART should be implemented in HIV treatment programs in the Asia-Pacific -
Pro-standpoint
Con-standpoint
Edsel Salvana, MD, DTM&H, FPCP, FIDSA
University of the Philippines Manila, the Philippines
Saturday- 29/06/2019
Capacity-building session 3: Online clinical management tools -
Capacity building session 3
Parallel session 10: Novel diagnostics in STIs -
Novel molecular diagnostics to enhance antimicrobial stewardship of sexually transmitted infections in Asia-Pacific (Not yet available)
Rebecca Guy, PhD
Kirby Institute, UNSW, Australia
Parallel Session 11: Current Knowledge in Viral Hepatitis -
Chien-Ching Hung, MD, PhD
Hepatitis B Therapy Pipeline: How Far Are We From Cure
Peter Revill, PhD
Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Australia
Epidemic of Acute HCV: What Have We Learned?
National Taiwan University Hospital & National Taiwan University Hospital Yunlin Branch / National Taiwan University College of Medicine, Taiwan
Plenary Session 3: PrEP - demedicalization -
Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD
Provider’s Perspective of PrEP Demedicalization
UNAIDS Regional Office for Asia and the Pacific, Thailand and the Global HIV, Hepatitis and STIs Programme, World Health Organisation, Switzerland
Community Perspective of Demedicalization of PrEP
The Use of Technology to Demedicalize PrEP
Overview
Welcome
The very successful 4th Asia Pacific AIDS & Co-infections Conference (APACC) took place from 27 to 29 June 2019 in Hong Kong.
Organizing Committee would like to thank all invited speakers and participants for their contribution to this conference!
We would like to thank our supporters including ViiV Healthcare, Gilead Sciences, Mylan, and Hong Kong Toursim Board for making this event possible.
General Information
Unique Features
- A program with a special focus on the needs in Asia and the Pacific
- A true scientific platform for regional clinicians and clinical researchers to present their data
- Insights into important clinical developments and updates on ongoing and new trials
- Capacity building workshops and career development sessions for young professionals
- A great opportunity to network with your colleagues throughout Asia
- A true scientific platform for regional clinicians and clinical researchers to present their data
- Insights into important clinical developments and updates on ongoing and new trials
- Capacity building workshops and career development sessions for young professionals
- A great opportunity to network with your colleagues throughout Asia
Meeting Objectives
This meeting aims to:
- Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
- Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice
- Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
- Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice
Learning Objectives
After participating in this activity, participants will be able to:
- Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region
- Identify improved treatment options for their patients
- Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
- Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings
- Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region
- Identify improved treatment options for their patients
- Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
- Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings
Practical Information
Certificate of Attendance
A digital certificate of attendance was sent to participants upon request by email.
Language
The official language of the conference was English.
Translation was not provided.
Translation was not provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this conference, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this conference. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official conference sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the conference is finished, provided the speaker has given permission to do so.
Committees
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Chien-Ching Hung, MD, PhD
- Ishwar Gilada, MD, DDV, FCPS
- Jun Yong Choi, MD, PhD
- Zhiwei Chen, PhD, DVM
Support
Titanium Level
Bronze Level
Contributor Level
CPG Supporter
Media
Image
Language
Related Programs
